Get the facts as we advise U.S. policymakers on pending legislation that would impact our customers’ ability to innovate and provide patient access to life-saving treatments.
ANNOUNCEMENT ON THE REPURCHASE AND CANCELLATION OF PART OF RESTRICTED A SHARES UNDER THE RESTRICTED A SHARES AND STOCK OPTION INCENTIVE PLAN OF 2018[2019-3-22]